Poly Medicure Limited has informed the Exchange about Granting of Options of Equity Shares under ESOS, 2020 of the Company.
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure Limited has approved the grant of 97,526 stock options to its employees under the Employees Stock Option Scheme (ESOS) 2020, as decided by the Nomination and Remuneration Committee on June 4, 2025. Each option can be converted into one equity share of the company at an exercise price of INR 100 per share, which is a discount to the market closing price on the grant date. The options will not vest for one year, after which vesting will happen over a maximum period of four years, and the exercise window is up to three months from each vesting date. The scheme complies with SEBI (SBEB) Regulations, 2021. No options have been vested, exercised, or lapsed as of this grant.
This is a routine employee compensation announcement with a minor dilution potential of 97,526 shares, which is small relative to the company's overall share base. The discounted exercise price of INR 100 may modestly dilute earnings per share in the long term once options are exercised, but is unlikely to have a material short-term impact on the stock price.